Targeting KRAS G12D Mutant for the Potential Treatment of Pancreatic Cancer

ACS Med Chem Lett. 2021 Oct 19;12(11):1643-1645. doi: 10.1021/acsmedchemlett.1c00545.

Robert B Kargbo ¹

Affiliations

Affiliation

1 Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.

PMID: 34795853 DOI: 10.1021/acsmedchemlett.1c00545

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-139894

KRAS G12D inhibitor 5

Ras Inhibitor

Ras

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us